Home Tags AbbVie

Tag: AbbVie

Allergan

Allergan With Settle With Restasis Payers For $30M

AbbVie subsidiary Allergan will pay about US$30 million to resolve the remainder of a consolidated antitrust class action over its alleged scheme to delay...
AbbVie

FTC Drops Antitrust Case Against AbbVie

AbbVie will not be pursued any further by the US government over allegations that it used "sham" litigation to keep competition to its AndroGel...
AbbVie

SCOTUS Rebuffs AbbVie Appeal In Patent Suit

The US Supreme Court on Monday, June 21, declined to hear AbbVie’s challenge to a lower court’s decision that it violated federal antitrust law...
Abbvie

AbbVie Unit To Face Antitrust Trial On Alzheimer Drug

AbbVie unit Forest Laboratories and another drug company lost their bid Friday to head off an antitrust trial in federal court in Manhattan over...
AbbVie

House Dems Ask FTC To Probe AbbVie’s Pricing Of Humira

Three House Democrats called on the Federal Trade Commission (FTC) to investigate drugmaker AbbVie for its pricing of Humira, the best-selling drug in the...
Abbvie

California AG Joins Coalition Against AbbVie’s Alleged Anticompetitive Practices

California Attorney General Xavier Becerra has joined a coalition of 20 state attorneys general in filing an amicus brief in the US Court of...
Abbvie

Humira Generic Delay Case Against AbbVie, Amgen, Sandoz Appealed

AbbVie, Amgen (a Samsung subsidiary), and Novartis unit Sandoz will face an appeal to the Seventh Circuit of antitrust claims over patent infringement settlements...
Abbvie

AbbVie Dodges Antitrust Challenge to Its Humira ‘Patent Thicket’

AbbVie Inc., Amgen Inc., a Samsung subsidiary, and Novartis unit Sandoz Inc. don’t have to face antitrust claims over patent infringement settlements that delayed generic competition for the blockbuster arthritis drug...
Abbvie

AbbVie Antitrust Case Atty Now Manager at FTC

Federal Trade Commission attorney Patty McDermott, who led the agency’s 2018 antitrust trial against pharmaceutical giant AbbVie Inc., is now a manager at the...
Abbvie

AbbVie Wins US Antitrust OK To Buy Allergan

AbbVie won US antitrust approval for its acquisition of Botox maker Allergan, clearing the last hurdle from competition regulators to the $63 billion deal. The Federal...
Enable Notifications    OK No thanks